Evidence map›Paper›PMID 39394491›Full record

Observational studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Retinal oxygen metabolic function in choroideremia and retinitis pigmentosa.

Dominique Prétot, Maria Della Volpe Waizel, Karolina Kaminska, Philippe Valmaggia, Giorgio Placidi, Benedetto Falsini, Fabian N Fries, Nóra Szentmáry, Carlo Rivolta, Hendrik P N Scholl and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The effect of acute zonular occult outer retinopathy on retinal vessel oxygen saturation.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dominique Prétot *Department of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Maria Della Volpe Waizel *Department of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Karolina KaminskaDepartment of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Philippe ValmaggiaDepartment of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Giorgio PlacidiOphthalmology Unit, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS/Università Cattolica del S. Cuore, Rome, Italy.
Benedetto FalsiniOphthalmology Unit, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS/Università Cattolica del S. Cuore, Rome, Italy.
Fabian N FriesDr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg, Saar, Germany.
Nóra SzentmáryDr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg, Saar, Germany.
Carlo RivoltaDepartment of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Hendrik P N SchollDepartment of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland.
Giacomo CalzettiDepartment of Ophthalmology, University Hospital Basel, University of Basel, Basel, Switzerland. giacomo.calzetti@iob.ch.ORCID http://orcid.org/0000-0003-1391-9510

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo measure the retinal oxygen metabolic function with retinal oximetry (RO) in patients with choroideremia (CHM) and compare these findings with retinitis pigmentosa (RP) patients and controls.

methodsProspective observational study including 18 eyes of 9 molecularly confirmed CHM patients (9♂; 40.2 ± 21.2 years (mean ± SD), 77 eyes from 39 patients with RP (15♀ 24♂; 45.6 ± 14.7 years) and 100 eyes from 53 controls (31♀ 22♂; 40.2 ± 13.4 years). Main outcome parameters were the mean arterial (A-SO

resultsEyes suffering from CHM differed significantly from both RP and control eyes, when the retinal oxygen metabolic parameters were taken into account. While RP showed significantly higher A-SO

conclusionThe retina in CHM is a relatively hypoxic environment. The decrease in oxygen levels may be due to the profound choroidal degeneration, leading to decreased oxygen flux to the retina. RO measurements may help understand the pathogenesis of CHM and RP. These findings may provide useful details to inform the planning of clinical trials of emerging therapies for CHM. KEY MESSAGES: What was known before? Retinal oxygen metabolic function measured with retinal oximetry (RO) shows significant alterations in patients with retinitis pigmentosa. WHAT THIS STUDY ADDS: RO function in choroideremia is significantly altered when compared to controls. Furthermore, RO in choroideremia shows opposing findings within different oxygen metabolic parameters to those that were so far known for retinitis pigmentosa. By providing insights into the retinal oxygen metabolic mechanisms, RO can help understand the underlying pathophysiology in choroideremia.

Indexed as

ChoroideremiaOxygenOxygen ConsumptionOxygen SaturationRetinaRetinal VesselsRetinitis PigmentosaAdultFemaleFollow-Up StudiesFundus OculiHumansMaleMiddle AgedOximetryProspective StudiesOxygenChoroideremiaInherited retinal diseasesRetinal oximetryRetinal oxygen metabolic functionRetinitis pigmentosa

Identifiers

PMID39394491
PMCPMC11868133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.